Jul. 8, 2009 (Baystreet.ca) --
Newark, DE – Every trading day PennyStockChaser.com sifts through thousands of stocks to identify those that are poised and ready to move up. Penny Stock Chaser is monitoring Gasco Energy Inc. (AMEX:GSX), IA Global Inc. (AMEX:IAO), Neah Power Systems Inc. (OTCBB:NPWS), The Steak n Shake Co (NYSE:SNS), Novogen (NASDAQ:NVGN). To receive more hot stock alerts, investors simply need to join our FREE newsletter service by visiting the following link: http://www.pennystockchaser.com/join-now/
The following stocks are expected to go higher:
Gasco Energy Inc. (AMEX:GSX) rose 11 percent to $2.35 on no news. The Company is a natural gas and petroleum exploitation, development and production company, which is engaged in locating and developing hydrocarbon resources, mainly in the Rocky Mountain region.
IA Global Inc. (AMEX:IAO) jumped 50% to $1.60. IA Global is a Business Process Outsourcing and Financial Services corporation targeting the B2B and B2C markets in the Asia Region, the US and Australia. In Japan, the Company is 100% owner of Global Hotline, Inc., a Business Process Outsourcing organization, operating several call centers providing outbound telemarketing services for telecommunications and insurance products.
Neah Power Systems Inc. (OTCBB:NPWS) rose up 6% to $0.12 after the Company announced that it has created and demonstrated the first air based fuel cell for aerobic applications. Neah Power Systems develops advanced, portable power fuel cells for mobile electronics applications contained in the military, commercial, and consumer market segments. Fuel cells are devices that combine a fuel, such as methanol, with an oxidant, such as oxygen gas, air, or other liquid oxidants in a chemical reaction at a catalyst surface to produce electricity.
The Steak n Shake Co (NYSE:SNS) moved up 11% to $9.02 on no news. The Company is engaged in the ownership, operation and franchising of Steak n Shake restaurants. Steak n Shake is a classic American brand serving premium burgers and milk shakes
Novogen (NASDAQ:NVGN) surged 47% to $4.18 after Researchers at the Malaghan Institute of Medical Research in Wellington, New Zealand have found that abnormally proliferating human T-cells, rapidly dividing cancer cells undergo programmed cell death when exposed briefly to the investigational anti-tumor drug phenoxodiol. Marshall Edwards has licensed rights from Novogen Limited (ASX: NRT) (NASDAQ:NVGN) to bring three oncology drugs -- phenoxodiol, triphendiol and NV-143 -- to market globally. Novogen Limited is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of isoflavonoid technology.
About PennyStockChaser.com
PennyStockChaser.com is an independent electronic publication that provides information on selected publicly traded companies. PennyStockChaser.com is not a registered investment advisor or broker-dealer. PennyStockChaser.com's affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
Michael Scott Jacobs, CFA, of PennyStockChaser.com is a member of the National Association of Securities Dealers, CRD number 1818665.
For further information, please contact:
Mike Schonberg, 1-866-469-8524
Email:editorial@pennystockchaser.com
http://www.pennystockchaser.com/